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Gongping Sun and Denise J. Montell*Abstract
Apoptosis is a form of programmed cell death that is
carried out by proteolytic enzymes called caspases.
Executioner caspase activity causes cells to shrink,
bleb, and disintegrate into apoptotic bodies and has
been considered a point of no return for apoptotic
cells. However, relatively recent work has shown that
cells can survive transient apoptotic stimuli, even after
executioner caspase activation. This process is called
anastasis. In this Q&A, we answer common questions
that arise regarding anastasis, including how it is
defined, the origin of the name, the potential
physiological consequences, molecular mechanisms,
and open questions for this new field of study.executioner caspase activity reaches its maximal levelWhat is anastasis?
Anastasis refers to cellular recovery from the brink of
apoptotic death. Anastasis is a process by which cells
survive executioner caspase activation following transi-
ent exposure to a lethal dose of an apoptotic stimulus. It
was first named in 2012 [1]. In this study, we applied
chemical toxins to mammalian cells in order to induce
apoptosis in a variety of cell types and waited until they
showed classic apoptotic hallmarks including activation
of caspase 3, cell shrinkage, and membrane blebbing. If
cells were left in the toxins, the vast majority of them
died. However, removing the chemical stress after a few
hours by replacing the growth medium allowed most
cells to recover a relatively normal morphology (Fig. 1).
This recovery is called anastasis, which is a Greek word
meaning ‘rising to life’. The word apoptosis is also de-
rived from Greek roots and means falling to death, like
leaves falling from trees or petals from flowers [2].* Correspondence: denise.montell@lifesci.ucsb.edu
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The discovery of anastasis shows that the activation of
the executioner caspases is not ‘the point of no return’
in apoptosis, which is a new concept. Apoptosis is a cell
suicide process that was initially described as a series of
morphological changes resulting in cell fragmentation
into apoptotic bodies and their subsequent removal by
phagocytosis [2]. After decades of study, the core mo-
lecular mechanisms regulating apoptosis are well-
established. While many different stimuli can initiate
apoptosis, they all ultimately cause the activation of
executioner caspase enzymes [3]. The activation of the
executioner caspases during apoptosis occurs rapidly. In
HeLa cells treated with apoptosis inducers, such as
staurosporine, or TRAIL together with cycloheximide,
within 20 min after the onset of activation [4–6]. Activa-
tion of the executioner caspases results in irreversible
proteolysis of numerous targets, which leads to dismant-
ling of the cell [7]. Thus, the classic view of apoptosis
has been that, after the activation of the executioner cas-
pases, death is inevitable.
Nevertheless, retrospectively, hints of anastasis can be
found in the literature. For example, a study in
Caenorhabditis elegans showed that some cells that are
normally destined to die by apoptosis during develop-
ment can live and go on to differentiate into neurons
when their removal by phagocytosis is prevented in ani-
mals bearing mutations in engulfment genes [8]. The
cells presumably recover from caspase activation, though
this has not been demonstrated directly. The fraction of
cells that recover increases from 3% to > 50% when one
copy of the gene encoding executioner caspase is
mutated in the same animals with defective phagocyt-
osis, which shows that this process is sensitive to caspase
levels, thus hinting that a threshold level of executioner
caspase expression is required to complete apoptosis.e is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Fig. 1. Apoptosis and anastasis. When cells experience a potentially lethal dose of a chemical stress, they simultaneously activate a pro-survival stress
response and initiate the apoptotic process, activating caspase 3. They poise for recovery by enriching some mRNAs encoding survival proteins. If the
stress persists, the apoptotic process dominates and the cells dissociate into apoptotic bodies. If the stress is relieved, cells undergo a
two-stage recovery. The early recovery involves transcription initiation, stress response, and re-entry into the cell cycle. The late recovery involves cytoskeleton
rearrangement and cell migration. Adapted from [9], ©2017 Sun et al. The Journal of Cell Biology. 216:3355–3368; DOI:10.1083/jcb.201706134
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Recovery from caspase activation after exposure to
multiple types of stimuli has been observed. These in-
clude: 1) chemical apoptosis inducers such as ethanol,
DMSO, staurosporine, jasplakinolide, and cucurbitacin
[1, 9]; 2) the death-inducing ligand TNFα combined with
cycloheximide [9]; 3) physical inducers such as cold
shock [10]; 4) physiological stress such as protein starva-
tion [10]. Further study will be needed to uncover the
diversity of apoptotic inducers from which cells can
recover.
What kinds of cells can undergo anastasis?
In vitro, anastasis has been observed in multiple cul-
tured cancer cell lines, including the cervical cancer cell
line HeLa and the glioma cell line H4. Anastasis has also
been observed in immortalized non-cancer cell lines like
NIH3T3 and in primary cells isolated from liver and
heart [1, 9, 11]. In vivo, evidence exists for anastasis in
epithelial tissues in Drosophila, mammalian cardiac
myocytes and neurons, and neuronal cells of C. elegans.
Despite the fact that anastasis has only relatively recently
been discovered, the variety of cell types and animals in
which it has been observed suggests that it may be gen-
eral to many if not all types of cells.
When and where does anastasis occur in vivo?
To determine where and when cells survive caspase acti-
vation in vivo, we developed a genetically encoded sen-
sor in Drosophila that converts transient executioner
caspase activation to permanent expression of a fluores-
cent protein. Therefore, all cells that survive executioner
caspase activation as well as their progeny are labeled.Using this tool, we found that many cells survive caspase
activation during larval and pupal development as well
as in the adult, in the absence of any external stress [12].
In contrast, few if any cells of the embryo survive cas-
pase activation, suggesting that the ability to undergo
anastasis changes during development.
In retrospect, several published examples may also
meet the definition of in vivo anastasis including, for ex-
ample, cardiac myocytes exposed to transient ischemia
in mice and rabbits [13]. Mouse neurons over-
expressing Tau protein survive caspase-3 activation and
develop tangles, though it is not clear if apoptosis was
initiated [14]. The discovery of anastasis in mammals
and flies suggests that it is an ancient and evolutionarily
conserved cellular process.
What is developmental anastasis?
In Drosophila, we were surprised to find cells that sur-
vive caspase-3 activation in larval imaginal discs and the
optic lobes of the larval brain, where the executioner
caspases are dispensable for tissue development. In such
tissues, where cell survival of caspase activation ap-
peared sporadically in both space and time, we propose
that the cells have undergone ‘developmental anastasis’
[12]. Since it is mainly observed in proliferating tissues,
we hypothesize that, in rapidly growing tissues, some
cells may randomly experience transient stresses, such
as a shortage of growth factors or mechanical
compression, leading to caspase activation. Some cells
with active caspase die, whereas others ultimately
survive transient caspase activation through anastasis.
Consistent with this interpretation, cell crowding causes
caspase activation during development of the pupal
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are extruded basally and die by apoptosis, whereas
others exhibit transient caspase activation and yet sur-
vive [15]. This seems to be a particularly clear example
of what may be a general phenomenon. That is, during
development, cells compete with one another for re-
sources including space, nutrients, and growth factors.
Cells lacking sufficient resources initiate the apoptotic
pathway. However, the death of some cells may actually
relieve the stress on the others, liberating resources and
allowing them to recover.
What is the difference between anastasis and
non-apoptotic caspase activation?
It has been clear for some time that some cells activate
either initiator or executioner caspases as part of normal
development, without causing cell death (recently
reviewed in [16]). In some cases, the caspase activities
are localized to particular compartments in the cell and
result in partial cellular destruction. An example of this
type of non-apoptotic caspase function occurs in sperm
maturation, dendrite remodeling, and nuclear destruc-
tion in mature lens fiber epithelial cells and red blood
cells. What these examples have in common with ana-
stasis is sublethal activation of caspases and survival of
the cell. What is different is that the cells are not at risk
of dying. In anastasis, cells experience a stress capable of
killing them if it persists long enough, whereas in cells
in which caspase activity performs a normal function,
the activity level and/or localization are restricted so as
to prevent death. The mechanisms that restrict caspase
activity are not yet fully understood.
Both cells that survive non-apoptotic caspase
activation and cells that undergo anastasis activate
CasExpress, the genetically encoded reporter of cells that
survive caspase activation [12]. Operationally we can
distinguish cells with non-apoptotic CasExpress from
cells that have undergone anastasis. A common charac-
teristic of non-apoptotic caspase activation is that it oc-
curs in a specific stage of development and in every cell
of the same type in the tissue. In contrast, developmen-
tal anastasis occurs in a random fraction of cells, sporad-
ically over time, in tissues with sporadic apoptosis [12].
Is anastasis simply arrest of the apoptotic
process?
No, transcriptome profiling of ethanol-exposed HeLa
cells showed that anastasis is an active process com-
posed of two distinguishable stages, rather than simply
arrest of the apoptotic process. The early stage involves
transcription of many transcription factors, stress re-
sponse, re-entry into the cell cycle, and proliferation.
Cells in the late stage undergo cytoskeletal rearrange-
ment and morphological change and become moremigratory [9]. So, the survivors are not ‘zombies’ but can
proliferate and migrate.
Are there other examples of cells surviving
caspase 3 activity under stress and are these the
same as or different from anastasis?
In 2015, Liu et al. reported that MCF10A cells can sur-
vive with activated caspase 3 after exposure to low-dose
56Fe ion irradiation (<3 Gys) [17]. Recently, the same
group reported some MCF10A cells can escape cell
death induced by Myc overexpression even though cas-
pase 3 was activated [18]. Ichim et al. found ABT-737, a
prototypic BH3-mimetic compound, induced mitochon-
drial outer membrane permeabilization (MOMP) in a
small fraction of mitochondria, leading to sublethal cas-
pase 3 activation [19]. In these studies, although caspase
3 was activated, no other apoptotic hallmarks were re-
ported, so it is unclear whether the apoptotic process
was initiated. In contrast, in experiments designed to de-
tect anastasis, we observe cell shrinkage, membrane
blebbing, and Annexin V staining in the majority of cells
treated with the apoptotic inducer, prior to washing and
recovery [1, 9]. Although the majority of work in the
apoptosis field suggested that caspase activation was an
all-or-nothing event [5–7], other work implies that dif-
ferent cells have different thresholds for the lethal level
of caspase 3 activity [20].
Is anastasis the only example of a reversible cell
death process?
No. Cells can recover from a variety of near-death expe-
riences. A process called resuscitation was recently dis-
covered, which refers to the recovery from near death in
cells undergoing necroptosis [21]. Even the dramatic
form of cell death known as entosis, in which one cell
swallows another alive, turns out to be reversible [22]:
the internalized cell can emerge to live again.
What are the molecular mechanisms that allow
cells to recover from the brink of death?
Whole transcriptome sequencing of HeLa cells during
recovery from ethanol-induced caspase activation re-
vealed that anastasis is a complex process involving
burst of transcription, stress responses, survival, prolifer-
ation, and production of angiogenic factors. More than
1000 genes are upregulated during early recovery [9].
Interestingly the molecular features of anastasis overlap
to some extent, but are also clearly distinguishable from,
the molecular response of cells recovering from a differ-
ent type of growth-arresting stress, autophagy [9].
Pharmacological inhibition of transcription, BCL-2,
XIAP, MDM2, or heat shock protein 90 suppresses
recovery from ethanol-induced caspase activation in
primary cells, suggesting the requirement for new
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proteins in anastasis [1]. Further study is needed to iden-
tify the key regulators of anastasis.
The transcriptional profiles of cells undergoing anasta-
sis revealed that the transcripts of some genes that were
highly upregulated during early recovery accumulated
already before removal of the apoptotic stimulus. This
finding suggests that cells poise for recovery while under
apoptotic stress, by enriching the mRNAs for specific
genes, which may facilitate rapid recovery after removal
of the stress (Fig. 1). One example is Snail. The mRNA
encoding Snail is enriched in apoptotic cells and further
elevated during early recovery. Cells with Snail knocked
down show significantly lower capacity to recover from
ethanol or staurosporine-induced caspase activation than
control cells. However, inhibition of TGFβ signaling,
which blocked Snail expression after 4-h recovery, did
not affect survival, confirming that it is the ‘poised’ Snail
that is essential [9].
Does anastasis cause any permanent changes in
cells?
In our previous study, we found a small fraction of NIH
3T3 fibroblast cells that survive caspase activation after
transient exposure to a lethal dose of ethanol showed
chromosomal aberrations and underwent oncogenic
transformation [1]. However, it is not known if the major-
ity of cells that have undergone anastasis retain any gen-
etic or epigenetic mark of their near-death experience.
Why might cells have evolved the ability to
undergo anastasis?
The discovery of anastasis unveils a new survival strategy
in both normal and cancer cells. Apoptosis appears to
have evolved as a mechanism to eliminate cells that are
potentially harmful such as autoreactive T cells or cells
with DNA damage, so what is the benefit of rescuing
cells from the brink of apoptotic cell death when such
rescue runs the risk of preserving cells that might do
harm? A working hypothesis is that anastasis evolved to
limit the permanent tissue damage that would otherwise
occur in response to a severe but transient injury, radi-
ation exposure, or chemical stress.
What are the potential implications of anastasis
for cancer?
Radiation and many commonly used chemotherapy
drugs induce apoptosis (reviewed in [23, 24]) and are de-
livered transiently due to their toxicity. So, if tumor cells
coopt the normally beneficial recovery process of anasta-
sis, and thus escape therapy-induced cell death, anastasis
could underlie relapse following treatment. Anastasis
has been observed in cancer cell lines [1, 9], and a frac-
tion of cervical cancer cells that have undergoneanastasis exhibit changes in cell morphology and be-
come more migratory [9]. Therefore, by promoting sur-
vival and migration, anastasis in tumor cells may
contribute to metastasis. Thus, studying the mechanisms
underlying anastasis and finding methods to enhance or
inhibit it may provide new treatment strategies for
cancer.
What are the future directions for anastasis
research?
There are many open questions for anastasis research.
What are the earliest events in the process that allow
cells to recover even before new gene transcription takes
place? Are there permanent epigenetic changes in cells
that have undergone anastasis? Are cells that have
undergone anastasis more—or less—resilient to future
stresses? What is the true point-of-no-return during
apoptosis? Can we identify small molecule or biological
enhancers or inhibitors of anastasis for use in treating
heart attacks, strokes, cancer, and neurodegeneration?
Are there cell-type-specific and/or drug-specific features
of anastasis that we can exploit therapeutically? Is there
a core, conserved mechanism that is the same in all cell
types? These and many other questions will be the sub-
ject of ongoing and future research in this exciting new
field of study.
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